weight loss information
|
GIP Hormone - Weight Loss Drug Treatment to Reduce ObesityA hormone secreted by the intestine after a high-fat meal may be a likely target for anti-obesity drugs in the future, preliminary study findings suggest. The hormone is called gastric inhibitory polypeptide (GIP) and researchers in Japan have bred mice that lack a receptor for the hormone. These mice did not gain weight when they were fed a high-fat diet and did not develop insulin resistance--a precursor to type 2 diabetes that often occurs in obese individuals, according to a report in the June 17 advance online publication of Nature Medicine.
The researchers, led by Dr. Yutaka Seino from Kyoto University, found that mice bred to lack the GIP receptor and the so-called obesity hormone, leptin, were even slimmer than mice lacking only the receptor. Leptin, a hormone released by fat cells, is thought to notify the brain to curb its appetite when fat cells are full. It seems that mice that lack the receptor tend to burn dietary fat as fuel, rather than stockpiling it in fat cells, according to Seino and colleagues. The findings suggest that GIP plays a role in obesity and "is a potential target for anti-obesity drugs," the study authors conclude. Source: Nature Medicine 2002 Articles About Weight Loss Drugs |
|